CELLECTIVE THERAPEUTICS
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.
CELLECTIVE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Status:
Active
Total Funding:
27.5 M USD
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
CisThera
CisThera is a private biopharmaceutical company that is developing novel therapeutics for cancer and autoimmune diseases.
Keyhole Therapeutics
Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases.
Current Employees Featured
Founder
Investors List
MedImmune Ventures
MedImmune Ventures investment in Series A - Cellective Therapeutics
BA Venture Partners
BA Venture Partners investment in Series A - Cellective Therapeutics
Genentech
Genentech investment in Series A - Cellective Therapeutics
Intersouth Partners
Intersouth Partners investment in Series A - Cellective Therapeutics
Alta Partners
Alta Partners investment in Series A - Cellective Therapeutics
Forward Ventures
Forward Ventures investment in Series A - Cellective Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - Cellective Therapeutics
Latterell Venture Partners
Latterell Venture Partners investment in Series A - Cellective Therapeutics
More informations about "Cellective Therapeutics"
Cellective Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Cellective Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cellective Therapeutics - Funding, Financials, Valuation & Investors
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.See details»
Cellective Therapeutics - Products, Competitors, Financials, โฆ
About Cellective Therapeutics Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder โฆSee details»
Cellective Therapeutics - Company Profile - Tracxn
Feb 20, 2025 Cellective Therapeutics - Biotech research company working on B Cell Research for cancer and autoimmune diseases, acquired by MedImmune in 2005. Raised a total funding โฆSee details»
Cellective AI
Cellective AI is pioneering next-generation cancer treatment by training immune cells with AI-driven technology. Discover how we are transforming immunotherapy without genetic โฆSee details»
Cellective Therapeutics - intersouth
Cellective Therapeutics Cellective Therapeutics was founded with technology created by Dr. Tom Tedder, a recognized world leader in B-cell biology and Chairman of the Department of โฆSee details»
Cellective Therapeutics Inc - Company Profile and News
Company profile page for Cellective Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Cellective Therapeutics - Ownership and Business Overview - Mergr
Cellective Therapeutics was a biopharmaceutical company focused on developing monoclonal antibodies for the treatment of oncology and autoimmune diseases such as B-cell lymphoma, โฆSee details»
Cellective Therapeutics, Inc. | Company | Mindmaps
Cellective Therapeutics was founded with technology created by Dr. Tom Tedder, a recognized world leader in B-cell biology and Chairman of the Department of Immunology at Duke University.See details»
MedImmune Completes Cellective Acquisition - bionity.com
MedImmune, Inc. announced that it has completed its acquisition of Cellective Therapeutics, Inc., a private Maryland-based biopharmaceutical company focused on the development of โฆSee details»
Cellective BioTherapy - Crunchbase Company Profile & Funding
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.See details»
Thomas F. Tedder - Founder, CEO & Director at Cellective โฆ
He founded Cellective Therapeutics in 2003 with the largest Series A financing in the Southeast at that time. The company was acquired by MedImmune/AstraZeneca in 2005. In 2015, he โฆSee details»
Lisa-Beth Ferstenberg, M.D. | miRecule
She was founding CEO of Cellective Therapeutics, Inc., a venture backed company that developed a monoclonal antibody for autoimmune indications, which was acquired by โฆSee details»
Cellective Therapeutics, Inc - VentureRadar
IntelliWheels, Inc., is a startup company out of the University of Illinois at Urbana-Champaign that develops technology to improve mobility options for wheelchair users. It was founded by Scott โฆSee details»
MedImmune to buy Cellective Therapeutics - Fierce Biotech
Sep 13, 2005 Gaithersburg, Maryland-based MedImmune has signed a deal to buy Cellective Therapeutics in an all-cash transaction. MedImmune didn't say how much it was paying for โฆSee details»
MedImmune Gaining Antibodies Through Cellective Acquisition
Sep 15, 2005 A year after raising $27 million in its Series A round, Cellective Therapeutics Inc. is being acquired by its larger neighbor, MedImmune Inc. The move might be somewhat of a โฆSee details»
Matt Jenkins - QHP Capital
Prior to Allscripts, Mr. Jenkins was one of the three founding members of Cellective Therapeutics (acquired by Medimmune), a biopharmaceutical firm focused on the development of โฆSee details»
Cellective Therapeutics, Inc.: ่ฏ็ฉ็ฎก็บฟ๏ผไธๅฉ๏ผไธดๅบ่ฏ้ช - ๆบๆ ง่ฝ โฆ
ไบ่งฃCellective Therapeutics, Inc.ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆฐ้ปใSee details»
Cellective Therapeutics-ๅจ่็ฝ - vbdata.cn
Cellective Therapeutics, Inc.ไธๅฎถ่ฏ็ฉๅผๅๅ ฌๅธ๏ผ่ดๅไบๅ็ฐใๅผๅๅๅไธๅ็จไบๆฒป็B็ป่็ๅ่ช่บซๅ ็ซ็พ็ ็ๅๅ ้ๆไฝใ ๅ ถไบงๅๅ ๆฌ้ๅฏนB็ป่ๆๅ็ๅๅ ้ๆไฝCD19๏ผCD20ๅCD22ๅค โฆSee details»
Federal government announces support for cutting-edge, AI- and โฆ
2 days ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for โฆSee details»